NCT06768359

Brief Summary

The goal of this clinical trial is to prove that the combination of acupuncture therapy and standard therapy is more effective in reducing anxiety and improving the quality of life of cancer patients. The main questions it aims to answer are:

  1. 1.Can the combination of manual acupuncture and standard therapy reduce anxiety based on Hamilton Anxiety Rating Scale (HAM-A) scores in cancer patients compared to the sham acupuncture and standard therapy group?
  2. 2.Can the combination of manual acupuncture and standard therapy improve the quality of life of cancer patients based on the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C-30 (EORTC-QLQ C30) compared to the sham acupuncture and standard therapy group?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at below P25 for not_applicable anxiety

Timeline
Completed

Started Mar 2025

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 23, 2024

Completed
18 days until next milestone

First Posted

Study publicly available on registry

January 10, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

March 24, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2025

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
Last Updated

January 8, 2026

Status Verified

January 1, 2026

Enrollment Period

8 months

First QC Date

December 23, 2024

Last Update Submit

January 7, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Hamilton anxiety rating scale (HAM-A) score

    One tool to measure the degree of anxiety symptoms is a questionnaire. Scores range from 0-56.

    6 days

Secondary Outcomes (1)

  • European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C-30 (EORTC-QLQ C30) score

    6 days

Study Arms (2)

Intervention Group

EXPERIMENTAL

The manual acupuncture and standard therapy

Procedure: Manual acupuncture and standard therapy

Control Group

SHAM COMPARATOR

The sham acupuncture and standard therapy

Procedure: Sham acupuncture and standard therapy

Interventions

Manual acupuncture is acupuncture needle insertion was done perpendicularly to the acupuncture points GV20, EXHN3, HT7, and PC6 using Huanqiu needle measuring 0.25 x 25mm with mild stimulation rotation technique at a speed of 60x/minute and needle retention for 30 minutes. Therapy was performed every day for 6 days. Standard therapy is anxiolytic drugs and supportive psychotherapy given to patients according to the decision of the psychiatrist treating the patient.

Intervention Group

Sham acupuncture is when acupuncture needles are inserted into acupuncture points, but do not actually penetrate the skin, only attached to the plaster. Therapy was performed every day for 6 days. Standard therapy is anxiolytic drugs and supportive psychotherapy given to patients according to the decision of the psychiatrist treating the patient.

Control Group

Eligibility Criteria

Age18 Years - 59 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients aged 18-59 years.
  • Diagnosed with cancer in the last 6 months
  • Experiencing moderate to severe anxiety (assessed by HAM-A Score \> 14)
  • Willing to participate in this study until completion and sign an informed consent.

You may not qualify if:

  • Cancer patients with unstable hemodynamics
  • Cancer patients with brain metastases
  • Patients who have been diagnosed with anxiety disorders and have received pharmacological therapy from psychiatrists before.
  • Patients who have contraindications to manual acupuncture (there are wounds or infections at the point to be punctured, patients are allergic to stainless steel, patients are phobic of needles)
  • Patients who are uncooperative and do not allow acupuncture therapy (patients who are restless, angry)
  • Patients with poor liver function (SGOT (Serum Glutamic Oxaloacetic Transaminase) /SGPT (serum glutamate pyruvate transaminase)values increase 2-3 times the normal value)
  • Patients with blood clotting disorders (platelets \<50,000, INR (International Normalized Ratio) \> 2)
  • Patients with neutropenia (Absolute neutrophil count \<1000)
  • Patients with overt DIC (disseminated intravascular coagulation) and acute venous or arterial thrombosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Universitas Indonesia

Jakarta Pusat, DKI Jakarta, 10430, Indonesia

Location

RS Kanker Dharmais

Jakarta, 11420, Indonesia

Location

MeSH Terms

Conditions

Anxiety DisordersNeoplasms

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • KEPK FKUI-RSCM

    The Health Research Ethics Commitee of Faculty of Medicine

    PRINCIPAL INVESTIGATOR
  • KEPK RS Kanker Dharmais

    The Health Research Ethics Commitee of Dharmais Cancer Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The participants, and outcome assessors will be blinded to group allocation
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: The manual acupuncture and standard therapy will be designed as the intervention group, while the sham acupuncture and standard therapy will be designed as the control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical doctor

Study Record Dates

First Submitted

December 23, 2024

First Posted

January 10, 2025

Study Start

March 24, 2025

Primary Completion

November 15, 2025

Study Completion

November 30, 2025

Last Updated

January 8, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations